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Abstract: Fighting bacterial resistance is one of the concerns in modern days, as antibiotics remain
the main resource of bacterial control. Data shows that for every antibiotic developed, there is a
microorganism that becomes resistant to it. Natural polymers, as the source of antibacterial agents,
offer a new way to fight bacterial infection. The advantage over conventional synthetic antibiotics is
that natural antimicrobial agents are biocompatible, non-toxic, and inexpensive. Chitosan is one of
the natural polymers that represent a very promising source for the development of antimicrobial
agents. In addition, chitosan is biodegradable, non-toxic, and most importantly, promotes wound
healing, features that makes it suitable as a starting material for wound dressings. This paper reviews
the antimicrobial properties of chitosan and describes the mechanisms of action toward microbial
cells as well as the interactions with mammalian cells in terms of wound healing process. Finally, the
applications of chitosan as a wound-dressing material are discussed along with the current status of
chitosan-based wound dressings existing on the market.
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1. Introduction
According to the Merriam-Webster Medical Dictionary, an antimicrobial is an agent that either
prevents and stops the growth of pathogen microorganisms or even kills them [1].
Antimicrobial agents have been used since at least 2000 years ago, when the Ancient Egyptians
and Greeks used different plant extracts and mold to treat infections [2]. Since the well-known
discovery of penicillin by Alexander Fleming in 1928 through to modern days, antibiotics have been
among the most commonly used drugs for treating pathogen infections [3]. Since the number of
new classes of antibiotics has decreased and no new classes have been discovered since daptomycin
and linezolid in the 1980s, optimizations of already-existing molecules or combinations of different
compounds are used for new commercialized products [4]. Figure 1 presents a schematic representation
of the mechanisms of action traditionally targeted by antibiotics: (1) disruption of the cell membrane,
(2) inhibition of nucleic acid synthesis (DNA/RNA), (3) inhibition of protein synthesis by acting on
ribosomes, (4) regulation of enzymes involved in cell wall biosynthesis, and (5) inhibition of folic acid
synthesis in the cytoplasm. A modern approach in order to combat antimicrobial resistance would be
finding newer targets or using alternative antimicrobials, either natural or synthetic compounds [5,6].
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Figure 1. Schematic representation of five basic mechanisms of antibiotic action against microbial 
cells. 
The need for developing new generations of antimicrobial agents is due to the existence of drug-
resistant pathogens and the emerging problem of microbial infections. Infections with antibiotic-
resistant pathogens are not only difficult to treat but also involve prolonged debility for patients and 
expensive healthcare [7]. Studies show that more than 70% of chronic wounds are exposed to 
microbial biofilm infections [8]. A microbial biofilm is described as a well-structured, three-
dimensional microbial aggregate that surrounds itself with a self-produced exopolymer matrix 
containing polysaccharides, proteins, and nucleic acids. [9–11]. The resistance of biofilm to antibiotic 
treatments may be explained by various molecular mechanisms [12]. These include, among others, 
(1) limited diffusion of drugs through the exopolysaccharide matrix [13], (2) the presence of persister 
cells, which will allow the repopulation of biofilms following antibiotic treatment [14], and (3) 
possibility of exchanging antibiotic-resistant genes between organisms within the biofilm [12]. 
Biofilms are by far less susceptible to antibiotics, compared to planktonic cells, and quorum-sensing 
molecules regulate biofilm formation and expression of specific properties. Also called autoinducers 
(AIs), quorum-sensing molecules, which regulate most virulence factors, have been identified in 
various bacterial species. Staphylococcus aureus and Pseudomonas aeruginosa, two species intensively 
studied regarding quorum-sensing molecules, are also commonly associated with chronic wound 
infections [10]. Treating wound infections is more difficult when a biofilm is present. The extracellular 
polymeric matrix protects the biofilm from inflammatory processes, which are crucial steps in wound 
healing [15]. The phagocytosis process and complement cascade activation are blocked and the 
exopolymer matrix represents itself a physical barrier against antimicrobial drug penetration into the 
wound. Leucocyte penetration and movement are also limited through biofilms; therefore, their 
ability to produce ROS (reactive oxygen species) is impaired [10]. 
Besides commonly used antimicrobials such as antibacterials, antifungals, antivirals, and 
antiparasitics, chemical and natural compounds are some other types of antimicrobial agents that are 
of great interest not only to the scientific community but also to the public in general, given the fact 
that antimicrobial resistance is a worldwide threat. In 2018, the European Centre for Disease 
Prevention and Control (ECDC) stated that nearly 33,000 die every year as a consequence of an 
infection with antibiotic-resistant bacteria [16]. Therefore, natural and synthetic molecules are an 
important source for developing new antimicrobials. Antimicrobial polymers are considered the new 
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heparin, poly-ε-lysine, gramicidin A, quaternary ammonium polyethyleneimine, and guanylated
polymethacrylate, but the most promising is chitosan [18].
Chitosan, a natural cationic polysaccharide consisting of (1→4)-2-amino-2-deoxy-β-d-glucan, is
the partially- to fully-deacetylated form of chitin [19]. For many years, there has been great interest
in the use of chitin since this biopolymer is the second most abundant after cellulose [20]. There are
various sources of chitin: crustacean shells, fungi and algae cell walls, insect exoskeletons, and mollusk
radulae [21–24]. Commercial chitin, (1→4)-2-(acetylamino)-2-deoxy-β-d-glucan, is obtained, following
demineralization and deproteinization processes, mainly from crustaceans shells [25,26], which are
byproducts of the seafood-processing industry. The seafood-processing industry creates a large
quantity of waste every year. About 75% of the total body mass of crustaceans ends up as byproducts
(head, tail, backbone, and shell) [27]. Due to a lack of better management of waste, most often,
seafood raw materials are discarded back into the sea, burned, or just left out to deteriorate, causing
environmental problems [28,29]. Therefore, the extraction of chitin and other valuable substances from
crustacean waste is an alternative that can reduce the waste and is an important step in producing
useful compounds that have important biological features and applications in various fields. According
to The State of World Fisheries and Aquaculture 2018 report by the FAO (Food and Agriculture
Organization of the United Nations), global farmed food fish production included approximately
7 million tons of crustaceans [30]. After the edible part of crustaceans has been removed, the remaining
material represents an important source of chitin as well as proteins, lipids, pigments, and other
molecules [28,31–33].
Unlike chitin, chitosan is soluble in acidic aqueous solution due to its acetylation degree.
The acetylation degree of chitosan can be expressed either as a percentage of acetylation (DA%)
or as the molar fraction of N-acetylated units (DA). Therefore, when the DA is lower than 50% (0.5),
dissolution is possible due to the protonation of the amino group at the C-2 position of glucosamine
units [34].
The physical-chemical characteristics of chitosan are important in order to understand its functional
properties. For example, the degree of acetylation, which refers to the distribution of amino groups
along the polymer chain, determines one of the most important features of chitosan, its polycationic
nature in acidic media, resulting from the ionization of amino groups. Thus, functional properties of
chitosan, such as solubility, swelling ratio, bioactivity, and biodegradation, are influenced by the degree
of acetylation. The molecular weight together with the deacetylation degree are the most important
physical-chemical characteristics of both chitin and chitosan. By manipulating the molecular weight
of chitosan, functional properties can be controlled; for example, viscosity can be reduced and water
solubility can be enhanced [35].
Chitosan is also an important tool in research fields due to its significant biological properties
such as biocompatibility and biodegradability [36–40], low toxicity [41–45], and antimicrobial [46–52],
antioxidant [49,53–56], and anti-cancer [57–62] properties. Due to all of the valuable features mentioned
above, chitosan is widely used in medicine and pharmaceutical fields, the food and agriculture industry,
as well as cosmetics and waste treatment [63–66].
In this review article, we will further discuss chitosan antimicrobial properties and describe its
mechanism of action against microbial cells, as well as the interactions with mammalian cells.
2. Chitosan Mechanism of Action against Pathogen Microorganisms
Chitosan is one of the most promising natural polymers known to possess antimicrobial
properties [67,68]. Interest in the antimicrobial properties of chitosan began many years ago, and
some of the first studies that described antimicrobial features of this biopolymer date back to the
1980s and 1990s [69,70]. The main conclusion highlighted by these studies was that chitosan has a
bacteriostatic and bactericidal effect, often without making any distinction between these two terms.
More recent studies tend to focus more on the bacteriostatic effect of chitosan, although the exact
mechanism of action against pathogens is not well known [71,72]. According to the literature, there are
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a few main generally accepted mechanisms of action of chitosan against microorganisms, which are
described below.
2.1. Disrupting the Cell Membrane/Cell Wall
Probably the most discussed mechanism refers to the alteration of cell permeability and lysis of
the cell membrane. This effect is presumably caused by electrostatic interactions between the positively
charged chitosan molecule and negatively charged cell membrane [73–84]. The antimicrobial activity
of chitosan is based on the presence of the amino groups of the polymer chain. These amino groups can
be protonated, giving chitosan a positive charge [78]. Therefore, chitosan becomes soluble in aqueous
acidic solutions when the pH value is lower than its pKa value of 6.3, in which case the –NH2 groups
are converted to a soluble protonated form −NH+3 [85,86]. The cell wall of Gram-positive bacteria is
composed mainly of a thick peptidoglycan layer containing teichoic acids, which give a negative charge
to the bacterial surface, while the Gram-negative bacterial cell wall is strongly negatively charged
due to lipopolysaccharides contained in the outer membrane layer. In addition, a similar situation
occurs in the case of the fungal membrane and viral envelope, which contain some negatively charged
compounds [87]. Fu et al. showed that teichoic acids contained in the cell wall of Staphylococcus aureus
interact with chitosan derivatives, thus inhibiting the growth of the bacteria, in some cases up to
approximately 100% [88]. Li et al. demonstrated that the cell membrane of Escherichia coli was damaged
by chitosan. They demonstrated extracellular leakage by measuring absorption at 260 nm and 280 nm,
estimating, in this way, the amount of DNA and proteins released from the cytoplasm. In addition,
electron micrographs obtained using transmission electron microscopy (TEM) revealed clear differences
between E. coli cells treated with chitosan and those used as a control. Chitosan-treated bacterial cells
showed a seriously altered outer cell membrane with cytosolic components coagulated after treatment
for 24 h [89]. Vallapa et al. demonstrated that the introduction of additional positive charges to chitosan
via heterogeneous quaternization increased the antibacterial activity against both Gram-positive and
Gram-negative bacteria, compared with native chitosan [90].
Chitosan may also exhibit antimicrobial activity against fungi. Here, the microorganisms can
be divided into two categories: chitosan-sensitive fungi and chitosan-resistant fungi. In this case,
the mechanism of action is slightly different from that of bacteria. First, chitosan molecules interact
with negatively charged phospholipids, thus affecting the cell membrane and causing the leakage
of intracellular material. However, in the case of chitosan-resistant fungi, this polymer seems to be
unable to penetrate the cell membrane, and it remains outside the cell surface [91,92]. The fluidity
difference of the cell membrane is presumably the reason why chitosan is unable to permeate the
cell membrane. The plasma membrane of chitosan-sensitive fungi has more polyunsaturated fatty
acids than chitosan-resistant fungi, which indicates that cell membrane disruption by chitosan may
depend on the fluidity of membranes [78]. Palma-Guerrero et al. showed that the phospholipid fatty
acid composition of the cell membrane is related to chitosan antimicrobial activity. To demonstrate
this, they tested the antimicrobial activity of chitosan against a fatty acid desaturase mutant strain of
Neurospora crassa, which exhibited increased resistance to chitosan compared to the wild type [92].
2.2. Interaction with Microbial DNA
Another mechanism consists of the interaction of chitosan hydrolysis products with microbial
DNA, thus affecting protein synthesis by inhibiting mRNA [78,93,94]. The ability to penetrate
a cell’s membrane and to enter in the cell was observed in the cases of low molecular weight
chitosans [72,95–97]. Xing et al. investigated the binding of oleoyl-chitosan nanoparticles (OCNPs)
to DNA/RNA by examining the effect of OCNPs on the electrophoretic mobility of nucleic acids.
The results showed that once the concentration of OCNPs increased, the interactions between bacterial
genomes multiplied, and by the time OCNP concentration reached 1000 mg/L, the migration of E. coli
DNA and RNA was completely inhibited. It is assumed that the negatively charged phosphate groups
in the chain of nucleic acids interact with the positively charged amino groups in OCNPs, thus affecting
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pathogen activity [83]. Galván Márquez et al. suggested that chitosan inhibits protein biosynthesis by
testing β-galactosidase expression assays. Their experiments showed that β-galactosidase activity in
yeast cells was reduced by 13% when chitosan concentration was 1.25 mg/mL [95].
2.3. Chelation of Nutrients by Chitosan
The high chelating capacity of chitosan towards various metal ions (Ni2+, Zn2+, Co2+, Fe2+,
Cu2+) when the pH value is higher than its pKa value could explain the inhibitory effect of chitosan
towards microbial growth [19,71,72,98–100]. Both Gram-positive and Gram-negative bacterial cell wall
components attract divalent metal cations that are beneficial to the microbial cell. The phosphate groups
of teichoic acids, contained in the peptidoglycan layer of Gram-positive bacteria, attract especially
Mg2+ and Ca2+ cations, which help to maintain enzymatic functions and the integrity of membranes.
Lipopolysaccharides, components of Gram-negative bacterial cell surfaces, give the bacterial cell
membrane a negative charge and also have a strong affinity for divalent cations [78]. The lack of these
divalent cations makes bacteria more sensitive to chemicals or certain antibacterial agents. Chelating
agents, such as ethylenediaminetetraacetic acid (EDTA) or some weak acids, can remove these cations,
making the cell wall a more permeable and less effective barrier [101]. It is known that chitosan has
chelating properties, so it can chelate metal ions and essential nutrients that are important for the
growth of the microbial cell [102–104]. At a low pH (below 6.0), the protonated amino groups in
the chitosan polymer chain compete with the divalent cations for the phosphate groups found in
the lipopolysaccharide or teichoic acid structure. Mansilla et al. showed that the addition of Mg2+
and Ca2+ to the culture medium increases the positive charge of the membrane and weakens the
antimicrobial action of chitosan, proving once again that the bacteriostatic action depends mainly on
electrostatic interactions [96].
2.4. Formation of a Dense Polymer Film on the Cell Surface
High molecular weight chitosan may deposit and form a dense polymer film on the surface
of the cell, preventing nutrient and oxygen uptake, which then inhibits the growth of aerobic
bacteria [93,105–107]. Champer et al. observed bacterial cells covered with chitosan aggregates using
an electron and fluorescence microscope [108]. Due to chitosan deposition, cell walls appeared thicker
and covered by an additional layer of vesicular structures. The thickness of the outer membrane
prevents the nutrients from entering the cell and also prevents the excretion of metabolic products [78].
3. Chitosan Interaction with Prokaryotic Cells
Often, bacteria need to survive even in the most hostile environments; therefore, they developed a
specialized cell envelope that is selectively permeable and protects the cell. The antimicrobial effect of
chitosan on prokaryotic bacterial cells depends on the electrostatic interactions between this polymer
and negatively charged components in the bacterial cell wall (Figure 2).
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Figure 2. Proposed interactions between chitosan and the bacterial cell wall. Electrostatic interaction 
between positively charged chitosan molecules and negatively charged lipopolysaccharides (Gram-
negative bacteria) and teichoic acids (Gram-positive bacteria) may lead to the blocking of 
intra/extracellular exchanges or even cell wall disruption and, finally, leakage of cytoplasmic content. 
3.1. Interaction with Gram-Positive Bacteria 
The difference between Gram-positive and Gram-negative bacteria is in their cell wall structure. 
When referring to Gram-positive bacteria, the main feature is the presence of teichoic acids, which 
can interact with chitosan molecules. Teichoic acids are anionic glycopolymers linked to the 
peptidoglycan layer that, among other functions, play an important role in pathogenesis, modulating 
susceptibility to cationic molecules. There are two types of teichoic acids: wall teichoic acids and 
lipoteichoic acid, which are anchored in the bacterial cell membrane. The resistance of Gram-positive 
bacteria to antimicrobial agents is through teichoic acids and their attached substituents that regulate 
the negative charge of the bacterial cell, which also prevents the binding of extracellular molecules 
[109]. This may also be the actual mechanism through which chitosan interacts with the Gram-
positive bacterial cell wall. Being positively charged, chitosan can interact with negatively charged 
teichoic acids, altering cell wall rigidity, disrupting the cell membrane, and eventually entering the 
cell. Moreover, the presence of D-alanine esters attached to teichoic acids contributes to the bacterial 
surface charge, and the reduction of D-alanyl content in the cell wall confers susceptibility to 
glycopeptide antibiotics and some cationic antimicrobial peptides [110]. Studies revealed that the 
absence of D-alanyl esters can increase the negative charge of the cell surface and facilitate the 
attraction of cationic molecules, thus increasing the sensitivity of the cell to such antimicrobials [111]. 
3.2. Interaction with Gram-Negative Bacteria 
Gram-negative bacteria have a more complex cell surface structure consisting of an outer lipid 
bilayer structure, the peptidoglycan cell wall, and the plasmatic membrane. The outer lipid bilayer is 
a distinct feature of Gram-negative bacteria, and its structure contains phospholipids in the inner 
layer and a single type of glycolipids, known as lipopolysaccharides (LPSs), in the outer layer. The 
outer layer is a selective barrier with two important features: (1) the selectivity, provided by the 
porins, which are small protein channels that diffuse certain hydrophilic molecules, and (2) the high 
negative charge, which is given by LPS molecules. The structure of LPS consists of the lipid A and 
the inner core, which are the negatively charged groups responsible for the interactions with cationic 
polymers. Lipid A can also be one possible target for neutralizing the endotoxic effect of LPS 
[112,113]. Davidova et al.’s study revealed that the interactions occur amongst LPS and the amino 
groups of chitosan. This was demonstrated using the anionic dye tropaeolin. Experiments showed 
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3.1. Interaction with Gram-Positive Bacteria
The difference between Gra -positive and Gra -negative bacteria is in their cell wall structure.
hen referring to Gram-positive bacteria, the main feature is the presence of teichoic acids, which can
interact with chitosan molecules. Teichoic acids are anionic glycopolymers linked to the peptidoglycan
layer that, among other functions, play an important role in pathogenesis, modulating susceptibility
to cationic molecules. There are two types of teichoic acids: wall teichoic acids and lipoteichoic
acid, which are anchored in the bacterial cell membrane. The resistance of Gram-positive bacteria to
antimicrobial agents is through teichoic acids and their attached substituents that regulate the negative
charge of the bacterial cell, which also prevents the binding of extracellular molecules [109]. This may
also be the actual mechanism through which chitosan interacts with the Gram-positive bacterial cell
wall. Being positively charged, chitosan can interact with negatively charged teichoic acids, altering cell
wall rigidity, disrupting the cell membrane, and eventually entering the cell. Moreover, the presence of
d-alanine esters attached to teichoic acids contributes to the bacterial surface charge, and the reduction
of d-alanyl content in the cell wall confers susceptibility to glycopeptide antibiotics and some cationic
antimicrobial peptides [110]. Studies revealed that the absence of d-alanyl esters can increase the
negative charge of the cell surface and facilitate the attraction of cationic molecules, thus increasing the
sensitivity of the cell to such antimicrobials [111].
3.2. Interaction with Gram-Negative Bacteria
Gram-negative bacteria have a more complex cell surface structure consisting of an outer lipid
bilayer structure, the peptidoglycan cell wall, and the plasmatic membrane. The outer lipid bilayer is a
distinct feature of Gram-negative bacteria, and its structure contains phospholipids in the inner layer
and a single type of glycolipids, known as lipopolysaccharides (LPSs), in the outer layer. The outer
layer is a selective barrier with two important features: (1) the selectivity, provided by the porins, which
are small protein channels that diffuse certain hydrophilic molecules, and (2) the high negative charge,
which is given by LPS molecules. The structure of LPS consists of the lipid A and the inner core, which
are the negatively charged groups responsible for the interactions with cationic polymers. Lipid A
can also be one possible target for neutralizing the endotoxic effect of LPS [112,113]. Davidova et al.’s
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study revealed that the interactions occur amongst LPS and the amino groups of chitosan. This was
demonstrated using the anionic dye tropaeolin. Experiments showed that at pH value between 4 and 7,
where the amino groups of chitosan are ionized, the LPS endotoxins displaced the negatively charged
dye molecules from the complex they formed with this cationic polymer [110]. Since porins are known
to be responsible for the uptake of nutrients [114], it is possible that chitosan molecules can block the
exchange of nutrients by forming a polymer layer on the surface of the cell, thus leading to bacterial
cell death.
4. Chitosan Interaction with Eukaryotic Cells
4.1. Interaction with Fungal Cells
As many studies show, chitosan can inhibit bacterial cell growth and even kill them, but regarding
yeast cells, only high concentrations of chitosan can have an antifungal effect and inhibit yeast cells
growth [71,87,115,116]. Since chitosan’s cationic nature is the result of the presence of reactive amino
groups in its structure, if these groups are blocked, antimycotic activity will be severely reduced [117].
The fungal cell wall is a unique structure, and its components are glycoproteins and polysaccharides,
mainly glucan and chitin. These structures are strongly cross-linked to form a resistant assembly that
will protect the fungal cell from environmental stress but at the same time will allow the fungal cell to
interact with its environment.
Each component of the cell wall is responsible for ensuring cell integrity. For example, if chitin
synthesis is perturbed, the fungal cell wall becomes osmotically unstable and deformed. The synthesis
of β-1, 3-glucan is necessary for the normal development of fungal cell walls, and the glycoproteins are
responsible for maintaining cell shape, intracellular signal transmission, synthesizing other cell wall
components, and facilitating molecules absorption, but at the same time protecting the cell against
foreign substances [118].
The organization of glycan and proteins at the surface of the cell is unique for each fungal species.
The phosphate groups, located in the carbohydrate side chains of highly glycosylated cell wall proteins,
give the negative charge at the surface of the fungal cell [119]. Studies have demonstrated the presence
of sialic acid on the surface of Candida albicans cell walls [118,120]. Anionic groups at the surface of
the fungal cell give a high negative charge that could facilitate electrostatic interactions with different
molecules and the host cell [121]. As mannoproteins are the major components at the surface of
the cell wall and the sialic acids are considered terminal residue in the carbohydrate side chain of
mannoproteins [119], electrostatic interactions could occur between chitosan and the fungal cell surface.
Soares et al. demonstrated that sialic acids contributed to the electrical negative charge of the cell
surface by facilitating the adherence of fungal cells to a cationic substrate (poly-l-lysine) [120].
The mechanism by which chitosan inhibits fungal growth is not fully understood yet, but some
proposed theories are described below and represented in Figure 3:
(a) Chitosan is a cationic polymer that will interact with the negatively charged cell surface (due
to the presence of sialic acid) and can destabilize the electrical charge of the cell wall;
(b) Once the negative charge is decreased, the concentration of the cations at the surface is also
affected (mainly K+), and the difference between internal and external concentration leads to the efflux
of cations;
(c) This efflux of cations will further cause the hyperpolarization of the plasma membrane,
therefore causing an increased uptake of Ca2+ and the loss of negatively charged molecules (nucleotides,
phosphates, substrates for enzyme reaction), affecting the metabolism of the cell and altering important
metabolic pathways [122,123].
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Figure 3. Schematic representation of chitosan mode of action on a Candida albicans cell. The fungal 
cell surface is negatively charged due to the carbohydrate side chains of mannoproteins, mainly sialic 
acids. Cationic chitosan molecules can cause ionic interactions with anionic groups and destabilize 
the cell wall. Other mechanisms of action proposed in the literature are metal chelation, enzyme 
denaturation, and chitosan interaction with phosphate groups of nucleic acids, all causing growth 
inhibition or even microbial death. 
Moreover, chitosan may form a dense film on the cell surface, which may interfere with fungal 
growth and activate several defense mechanisms such as chitinase accumulation, callus synthesis, 
and proteinase inhibitor synthesis and lignification [43]. Another hypothesis, by which yeast cells 
may recover after long exposure to chitosan or even gain resistance, is the existence of chitinases that 
may degrade deacetylated chitosan [124,125]. In their study, Oliveira Junior et al. reported that 
chitosan caused morphological changes and abnormal shapes of fungal mycelia. They tested the 
effect of chitosan with different molar fractions of acetyl groups (FA 0.16 and 0.18) and degrees of 
polymerization (DP 1089 and 1242), and both types of chitosan had a direct influence on the three 
fungal species studied (Alternaria alternate—500 μg/mL, Botrytis cinerea—1000 μg/mL, Penicillium 
expansum—500 μg/mL). Besides causing a delay in their growth, the micrographs also showed 
mycelial aggregations, excessive branching, hyphae size reduction, and swelling of the fungal cell 
wall [109]. Yien et al. concluded that C. albicans proved to be more susceptible to chitosan 
nanoparticles compared with other species [122]. One argument could be the presence of negatively 
charged sialic acids in the cell wall [120]. 
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tissue healing process [126]. 
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[127]. 
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Cationic chitosan molecules can cause ionic interactions with anionic groups and destabilize the cell
wall. Other mechanisms of action proposed in the literature are metal chelation, enzyme denaturation,
and chitosan interaction with phosphate groups of nucleic acids, all causing growth inhibition or even
microbial death.
Moreover, chitosan may form a dense fil on the cell surface, which may interfere with fungal
growth and activate several defense mechanisms such as chitinase accumulation, callus synthesis, and
proteinase inhibitor synthesis and lignification [43]. Another hypothesis, by which yeast cells may
recover after long exposure to chitosan or even gain resistance, is the existence of chitinases that may
degrade deacetylated chitosan [124,125]. In their study, Oliveira Junior et al. reported that chitosan
caused morphological changes and abnormal shapes of fungal mycelia. They tested the effect of
chitosan with different molar fractions of acetyl groups (FA 0.16 and 0.18) and degrees of polymerization
(DP 1089 and 1242), and both types of chitosan had a direct influence on the three fungal species studied
(Alternaria alternate—500 µg/mL, Botrytis cinerea—1000 µg/mL, Penicillium expansum—500 µg/mL).
Besides causing a delay in their growth, the micrographs also showed mycelial aggregations, excessive
branching, hyphae size reduction, and swelling of the fungal cell wall [109]. Yien et al. concluded that
C. albicans proved to be more susceptible to chitosan nanoparticles compared with other species [122].
One r ument coul be t e presence of negatively charged sialic acids in the cell wall [120].
4.2. Interactions with Mammalian Cells in ound Healing Processes
Despite the advanced development f a tise tics, i fections of wounds remain a major issue.
The emergence of multidrug-resistant path nstant n ed for mor efficient topical
antimicrobial products. The main dra st f the are highly cytotoxic, affecting the
tissue healing process [126].
Apart from antimicro i l antifungal properties, chitosan is innate, biocomp tible, and
non-toxic to living cells and tissue. Chitosan biocompatibility has been tested in vitro using different
types of cells like fibroblasts, keratinocytes, and hepatocytes, as well as myocardial and endothelial
cells [127].
Wounds heal naturally, but there are persons that suffer wound healing disorders, such as diabetic
patients who may develop chronic, non-healing wounds that subject the patients to long-term distress
and discomfort [113]. In such cases, a long treatment time is required, which will also increase the
costs associated with advanced medical care. Therefore, the focus has been on natural therapeutic
substances that can accelerate the wound healing process and at the same time be easily accessible
to the general population, and chitosan seems to meet all these conditions. Chitosan accelerates
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the wound healing process by stimulating inflammatory cells, macrophages, and fibroblasts, hence
boosting the inflammatory phase. In this way, the inflammatory phase is reduced, and the proliferative
phase starts sooner in the wound healing process [128].
Caetano et al. investigated the healing properties of a chitosan–alginate membrane on a cutaneous
wound in rats and observed the following: the wound was not infected, fibroplasia was significantly
increased, the fibroblasts were arranged better in the newly formed tissue, and the quality of scar
tissue was improved. Moreover, on the 7th day of treatment with the chitosan–alginate membrane,
the inflammatory infiltrate was significantly reduced, followed by a decrease of neutrophils and
CD4+ lymphocytes that might indicate a better regulation of the inflammatory stimulus by the
chitosan–alginate membrane. Likewise, the chitosan–alginate complex stimulated the migration of
CD11B+ macrophages. These cells are very important as they continue the work of neutrophils, acting
as growth factor reservoirs and releasing several enzymes that digest the remaining extracellular
content, facilitating the transition to the second phase of the healing process [112]. Chitosan may
also have the ability to regulate granulation tissue formation and angiogenesis, assuring the correct
deposition of collagen fibers and further enhancing the correct repair of injured dermal tissue [129].
When referring to the wound healing properties of chitosan, the hemostatic and analgesic effect of this
biopolymer should be considered. Chitosan’s unique hemostatic properties are independent of the
normal clotting cascades [130]. In addition, chitosan can interact with neutrophils and macrophages
and regulate the re-epithelialization process and fibroplasia [131,132].
Howling et al. showed that chitosan enhanced fibroblast proliferation, and it seems that the
proliferative effect is related to the deacetylation degree of the chitosan. The samples with a high
deacetylation degree (84% and 86%) increased the mitogenic activity in fibroblasts, while some samples
of chitin had an antiproliferative effect [133]. Possibly, the mechanism by which chitosan enhances
fibroblast proliferation is by forming polyelectrolyte complexes with growth factors, heparin, cytokines,
or other proteins found at a wound site [134].
At physiological pH, the applications of chitosan are limited due to its poor solubility and the
fact that the drug delivery process is less efficient at pH below 6. Therefore, in order to overcome
these drawbacks, permanent changes can be introduced into the chitosan backbone. Patrulea at al.
developed a water-soluble O-carboxymethyl-N,N,N-trimethyl chitosan (CMTMC) with a high degree
of substitution (up to 46.6%), which did not exhibit significant toxicity towards human dermal
fibroblasts (viability > 80% at 1 and 0.5 mg/mL) [135]. A more recent study published by Patrulea et al.
showed that formulations based on carboxylated and trimethylated chitosan (CMTMC) have great
potential in wound-healing applications. Foams and hydrogels with a high concentration of RDG
(arginyl-glycyl-aspartic acid)-functionalized chitosan (3%) and hyaluronic acid (1.5%) not only showed
no toxicity towards human dermal fibroblasts but also promoted proliferation over 7 days and the
migration of human dermal fibroblasts [136].
Both hemostatic and analgesic features may be attributed to the positive charge of chitosan.
Given the fact that the red blood cells are negatively charged, they can interact with cationic chitosan
molecules; therefore, chitosan’s hemostatic effect relies on electrostatic adhesion to blood cells [137].
The exact hemostatic mechanism of chitosan is yet to be fully understood, but theories rely on plasma
sorption, erythrocyte coagulation, and platelet activation and aggregation [138]. The protonated
amino groups of chitosan attract negatively charged red blood cells, triggering the hemagglutination
process [139]. Chitosan stimulates platelet aggregation and adhesion by adsorbing plasma proteins
and also signals thrombin, which is a clotting promoter, enhancing the expression of glycoprotein
IIb/IIIa (GPIIb/IIIa), a platelet membrane receptor [140]. The analgesic effect of chitosan has been
proven since 1984, when Allan et al. reported that chitosan provided a cool and southing effect when
applied on open wounds [141]. Huang et al. tested the analgesic effect of chitosan and carboxymethyl
chitosan on scalded rats by monitoring the concentration of bradykinin and 5-hydroxytryptophan,
potent algogenic substances, using an enzyme-linked immunosorbent assay. Results showed that in the
case of carboxymethyl chitosan treatment, the concentrations of bradykinin and 5-hydroxytryptophan
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were significantly lower than the control group (p < 0.05), but in the case of chitosan treatment, the
values were same as the control group (p > 0.05). Therefore, only carboxymethyl chitosan showed an
analgesic effect [142].
Chitosan’s structural characteristics are similar to glycosaminoglycans (GAGs), which are
components of the extracellular matrix (ECM); therefore, this feature recommends chitosan use
in skin tissue engineering [143]. The immobilization of bioactive molecules on the chitosan matrix,
such as cell-adhesive peptides, will stimulate the cell response and cell adhesion process. In this regard,
Karakeçili et al. have covalently immobilized mouse epidermal growth factor (EGF) on chitosan
membranes. The mouse EGF is responsible for fibroblast proliferation. The results indicated that EGF
has enhanced the proliferation of L929 mouse fibroblast cells [144].
Although there are published experimental data on how chitosan interacts with mammalian
cells involved in wound healing processes, there is still a lack of knowledge regarding innate sensing
of chitosan and the immunological response towards this polymer [145]; as polysaccharides are
recognized by the cell receptors and depending on their size and structure, may induce immune
responses [146]. The fact that chitin and chitosan are not present in mammalian cells makes them
potentially recognizable targets for the innate immune system. However, chitooligosaccharides could
be recognized by mammalian chitinases and finally degraded [145]. Another study revealed that
chitosan, but not chitin, had triggered inflammatory responses by activating NLRP3 inflammasome
in a phagocytosis-dependent manner. While chitosan was a potent NLRP3 inflammasome activator,
acetylation of chitosan to chitin resulted in an almost complete loss of activity [147]. Given the fact that
chitosan is used in various biomedical applications, research focusing on the immunological response
is of great relevance.
5. Factors Influencing Chitosan’s Antimicrobial Effect
Many research articles describe the influence that different factors have on the antimicrobial
properties of chitosan. Some of the most important factors include molecular weight and degree of
deacetylation, pH, type of microorganism, microbial growth media components, the source of the
chitosan, and also its derivatives [19].
5.1. The Molecular Weight and Degree of Acetylation
The molecular weight and degree of acetylation of chitosan define several properties of this
polymer [148]. The molecular weight of chitosan has a great influence on its biomedical properties.
Moreover, the degree of acetylation strongly influences its antimicrobial properties by increasing its
solubility and its positive charge. As shown in Figure 4, some physico-chemical properties such as
solubility, viscosity, and biocompatibility increase once the DA decreases, while crystallinity and
biodegradability are directly proportional to the DA. Biological properties such as antimicrobial,
analgesic, antioxidant, hemostatic, and mucoadhesive abilities increase once the degree of acetylation
is lower [149].
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Chitosans are often classified as high molecular weight (HMW), medium molecular weight
(MMW), and low molecular weight (LMW) [19], but the values for each type are not well defined and
the literature data is relative and sometimes even confusing (Table 1).
Table 1. Molecular weight of different types of chitosan.
Type of Chitosan Molecular Weight Range Reference
Oligochitosan 4.7 kDa [150]

















Published data show that the inhibitory mechanism of chitosan against pathogen microorganisms
is also related to its molecular weight. Thus, while HMW chitosan forms a dense layer on the surface
of the cell, preventing nutrient uptake [89], the much smaller chitosan molecules seem to penetrate
the membrane and even bind to DNA and RNA [98,159]. The antibacterial effect is dependent on
both molecular weight (MW) and type of microorganism. Tin et al. tested the antimicrobial activity
of four different MW chitosan samples (LMW, MMW, HMW, and chitosan oligosaccharide lactate)
against Pseudomonas aeruginosa. The results showed that the MIC (minimum inhibitory concentration)
values were higher for chitooligosaccharides (4096 µg/mL) compared to other chitosan samples
(32 µg/mL) [160]. Another study performed by Batista et al. illustrates the importance of MW on
antimicrobial activity. They have tested two types of chitosan (HMW and LMW) against E. coli
(Gram-negative), L. casei, and multiresistant strain S. aureus (both Gram-positive). Only MMW chitosan
was antibacterially active, and only against E. coli and L. casei, while S. aureus was resistant to both
chitosan samples [161]. As shown in Table 2, many other studies reported similar data regarding the
MW of chitosan and chitosan derivatives.
Table 2. Minimum inhibitory concentration (MIC) of different types of chitosan (C).






Cs oligosaccharide lactate 4096 µg/mL
Candida albicans
Cs 32 kDa 2 mg/mL
[162]Cs 38 kDa 2.3 mg/mL
Cs 138 kDa 2.5 mg/mL
Cs 184 kDa 3.3 mg/mL
Streptococcus mutans LMW Cs 2.5 mg/mL
[163]
Nano Cs 1.25 mg/mL
Streptococcus sobrinus LMW Cs 2.5 mg/mL
Nano Cs
Streptococcus sanguis LMW Cs 1.25 mg/mL
Nano Cs
Streptococcus salivarius LMW Cs 1.25 mg/mL
Nano Cs 2.5 mg/mL
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Staphylococcus aureus 80 µg/mL
Streptococcus sp. 60 µg/mL
Streptococcus pneumoniae 100 µg/mL
Escherichia coli 80 µg/mL
Staphylococcus aureus
Cs 41.1 kDa 32 µg/mL
[53]
Cs 14.3 kDa 32 µg/mL
Cs 5.06 kDa 32 µg/mL
Escherichia coli
Cs 41.1 kDa 64 µg/mL
Cs 14.3 kDa 32 µg/mL
Cs 5.06 kDa 16 µg/mL
5.2. pH Effect
The beneficial properties of this polymer depend strongly on its solubility, in either water or
other commonly used solvents. In its crystalline form, chitosan is soluble in aqueous solutions only
at a pH value under 7. Its solubility is due to the protonation of its amino groups under acidic
conditions. The main disadvantage of chitosan is its low solubility, and over the past years, there
has been a growing interest in the chemical modification of this polymer in order to improve its
solubility [149,165,166]. At a pH value of approximately 6.0, chitosan carries a positive charge, being
able to interact electrostatically with various negatively charged molecules. Therefore, the antimicrobial
mechanism of chitosan is pH-dependent.
As described earlier in this paper, chitosan interacts with the negatively charged cell membranes
of bacteria and fungi, leading eventually to the death of the microbial cell [167]. Many studies show
that chitosan’s antimicrobial activity is minimal at higher pH conditions. Younes et al. demonstrated
that when reducing pH values, the adsorption on bacterial cell surfaces will increase, probably due to
the highly positive charge on the chitosan polymer chain [34]. On the contrary, at higher pH (above 6),
chitosan will lose its charge, and due to the deprotonation of its amino groups, it will precipitate
from solution. Devlieghere et al. observed during their study that native chitosan showed greater
antifungal activity against Candida lambica at a pH value of 4.0 rather than 6.0 [106]. Helander et al. also
observed a greater antimicrobial effect of chitosan at lower pH conditions, while the inhibitory activity
decreased with increasing pH [77]. Erdem et al. tested the influence of pH on the antimicrobial activity
of chitosan against two strains: S. aureus and Aeromonas hydrophila. The pH values selected were 5.0,
6.0, 7.0, and 8.0. Chitosan showed an increased inhibitory effect at lower pH (5–6) against both strains,
reducing the viable cells from their initial populations to 1.80–0.57 log CFU/mL for A. hydrophila and
1.70–1.00 log CFU/mL in the case of S. aureus. In addition, they observed that unmodified chitosan
does not present antimicrobial activity at a pH of around 7.0 [168].
The results of Batista et al. are similar in that they observed the highest inhibitory effect of chitosan
against E. coli and Lactobacillus casei at a pH value of 5.7 (L. casei) and 5.5 (E. coli) [161]. While testing
the antifungal activity of LMW chitosan against several species of clinical isolates of Candida sp.,
Alburquenque et al. observed an increased inhibitory effect at a pH value of 4.0, with the MIC being
up to 4 times lower than at neutral pH. Their theory was also based on the fact that the increased
antifungal activity is due to the protonation of the amino group of chitosan units at pH 4.0, as the pKa
of LMW chitosan is 6.3 [169].
5.3. Source of Chitosan
Researchers have already investigated and compared the antimicrobial effect of chitosan extracted
from different sources. Tajdini et al. compared the antimicrobial effect of shrimp chitosan with fungal
chitosan against twelve bacterial and fungal species. The results showed that fungal chitosan was
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more efficient against P. aeruginosa, E. coli, Candida glabrata, and C. albicans in comparison to the shrimp
chitosan, the MIC values being twice smaller for fungal chitosan. Against the other microorganisms
tested, the antimicrobial effect was similar, and MIC values were the same for both types of chitosan,
indicating that fungal chitosan can be an effective and suitable alternative to shrimp chitosan [170].
Chien et al.’s study revealed that chitosan extracted from shiitake mushrooms was more effective than
shrimp chitosan against some of the pathogenic microorganisms tested [98]. Tayel et al. published
a study that showed that chitosan extracted from Mucor rouxii DSM-1191 exhibited pronounced
antifungal activity against different Candida albicans strains. Four types of fungal chitosan were
tested, and the most active against the fungal strain had the highest deacetylation degree (94%) and
the lowest molecular weight (32 kDa). [162]. Moussa et al. also demonstrated that fungal chitosan
(deacetylation degree of 89.2% and a molecular weight of 2.4 × 104 Da) extracted from Aspergillus niger
mycelia had a high antimicrobial effect against two foodborne pathogens (Salmonella typhimurium and
Staphylococcus aureus) [171].
Extraction of chitosan from fungal sources has many advantages over crustacean sources:
(a) Eliminates the harsh chemical processes that may cause environmental pollution;
(b) The raw material can be available throughout the entire year, and there are no risks of heavy
metal contamination;
(c) The demineralization step is no longer necessary for the extraction of chitosan from fungal mycelia;
(d) Different types of waste products can be used to grow fungal cultures, reducing marine
pollution by the removal of nitrogen, proteins, and other compounds from waste [107,117].
Moreover, as an alternative to crustacean-derived chitosan, fungal strains may be adapted to
industrial needs by applying genetic modifications in order to produce larger amounts of chitin for
further production of higher-quality chitosan [172].
However, some important advantages of chitosan extraction from crustacean waste are worth
mentioning. First, crustacean waste is an important source of pollution; therefore, obtaining chitosan
from this waste material will give value-added products. Furthermore, if enzymatic extraction methods
are used, the harsh environmental impact that chemical extraction methods involve will be reduced, and
the result will be a well-defined chitosan, obtained by a controlled, non-degradable process [173,174].
5.4. Type of Microorganism
It is a fact that chitosan possesses innate antimicrobial properties, and most studies show that
its antimicrobial properties depend on the type of microorganisms. Although most of the results
indicate that chitosan has a more pronounced antimicrobial effect on Gram-positive bacteria rather
than Gram-negative [175], the literature is contradictory, as other studies have demonstrated the
opposite [124,176]. For example, Fernandes et al. showed that the antimicrobial effect of chitosan was
dependent on the target microorganism as well as the molecular weight. Thus, chitooligosaccharides
had a higher antibacterial effect on Gram-negative species (E. coli, Klebsiella pneumoniae, P aeruginosa,
MIC values of 0.10%, 0.10%, 0.20%, respectively) compared with Gram-positive ones (S. aureus and
S. epidermidis, MIC values of 0.25% and 0.20%, respectively). In the case of Gram-positive bacteria,
high-molecular-weight chitosan exhibited a stronger antibacterial effect than chitooligosaccharides
(MIC values of 0.10% for both strains), while for Gram-negative bacteria, MIC values were higher
(0.25% for E. coli and K. pneumoniae and 0.5% for P. aeruginosa). Likewise, for C. albicans, the results
were rather similar to those detected for Gram-positive bacteria; chitooligosaccharides inhibited fungal
growth at an MIC value of 0.25%, while the MIC value for high-molecular chitosan was 0.15% [177].
The result of a study by Chung et al. showed that chitosan’s inhibitory effect was higher against
Gram-negative bacteria. Their hypothesis was related to the hydrophilicity of the bacterial cell wall.
The results obtained showed a greater hydrophilicity in Gram-negative bacterial cell walls then
Gram-positive ones; therefore, more negatively charged bacterial surfaces had greater interaction with
positively charged chitosan [178].
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A recent study on the antimicrobial effect of chitosan against bacterial contamination on the
surface on Iranian banknotes shows that the inhibitory effect is stronger against Gram-positive bacteria,
and a possibility of avoiding bacterial contamination through banknotes could be their coating with
chitosan [179].
The components found in the growth media used to cultivate the microorganisms may also
influence the antimicrobial properties of chitosan. Devlieghere et al. demonstrated that media food
components could influence the effect of chitosan on microbial growth. For example, 0.005% chitosan
was enough to inhibit Candida lambica growth, and small amounts of starch (1% w/v) did not affect
chitosan antimicrobial properties. However, high amounts of starch (30% w/v) significantly decreased
the activity of chitosan against C. lambica. In addition, only 1% of NaCl was enough to inhibit the
antimicrobial activity of chitosan [106].
5.5. Chitosan Complexes
The main purpose of producing chitosan complexes with other compounds is to improve its
beneficial properties, most of all, its antibacterial effects, and accelerate wound healing.
Various studies present different complexes between chitosan and other natural or synthetic
compounds in order to improve its antimicrobial effect and accelerate the wound healing process. For
example, Liu et al. developed an antibacterial material based on chitosan oligosaccharide-N-chlorokojic
acid mannich base (COS-N-MB). The resulting COS-N-MB complex with synergistic antibacterial effects
showed excellent inhibitory activity against pathogenic bacteria. The mechanism of action seems to rely
on the adsorption to bacterial cell walls through electrostatic interactions and chelating metal ions [125].
Biswas et al. developed two distinct wound-dressing materials by loading porous chitosan/poly(vinyl
alcohol) (CS/PVA) scaffolds with Ag and Se using an in situ deposition method. The Ag-CS complex
showed significant inhibition of bacterial growth and reduction of cytotoxicity to fibroblasts, while the
Se-CS complex damaged bacterial cell membranes and showed no toxicity towards fibroblasts [180].
Ma et al. observed that the incorporation of glycerol enhances mechanical properties and maintains
the good water vapor permeability and wettability of chitosan-based membranes [181]. The study of
Kaygusuz et al. demonstrated that cerium ion–chitosan crosslinked alginate films show antibacterial
activity against both Gram-negative (E. coli) and Gram-positive bacteria (S. aureus) and also show
high mechanic resistance, flexibility, and UV protection [182]. Anjum et al. developed antimicrobial
and scar-preventive wound dressings by blending chitosan (CS), polyethylene glycol (PEG), and
polyvinyl pyrolidone (PVP) on a cotton fabric. The cotton fabric was used as a support layer for the
CS-PEG/PVP gel; PEG increased the mechanical properties, and polyvinyl pyrolidone (PVP) helped
hydrogel formation [183]. Wahid et al. prepared Carboxymethyl chitosan (CMCh) supramolecular
hydrogels cross-linked by metal ions (Ag+, Cu2+, and Zn2+) that showed moldability, elasticity, high
mechanical properties, and a rapid and facile gelation process (within seconds). Moreover, the metal
ions added to the CMCh membranes significantly enhanced antimicrobial activity (Zn-loaded CMCh
membranes had higher efficiency against all bacteria tested) [184].
Although chitosan’s antibacterial activity is lower compared with conventional antibiotics, its
unique chemical behavior, namely the presence of three reactive functional groups (an amino group at
the C-2 position, a primary OH group at the C-6 position, and secondary OH groups at the C-3 position),
make this polymer available for further chemical modification in order to improve its antimicrobial
activity [72,125].
6. Chitosan Antimicrobial Wound Dressings
Wound infections can severely affect the healing process, and if not properly treated, they can
lead to sepsis and even to patient death [185]. The human skin acts as a barrier against external factors,
but when injured, it loses its efficacy and becomes vulnerable to pathogenic infections [186,187].
The ideal wound dressing (Table 3) should meet some requirements such as:
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(1) representing a physical barrier that is permeable to oxygen but at the same time maintains or
provides a moist environment; (2) sterile and non-toxic and protective against microorganism infections;
(3) providing an appropriate tissue temperature to favor epidermal migration and promote angiogenesis;
(4) non-adherent to prevent traumatic removal after healing [188]. All the above-mentioned properties
are characteristic of an ideal wound dressing, but it is difficult for one type of dressing the meet all
these requirements.
Table 3. Properties of an ideal wound dressing.
Characteristics of Wound
Dressing Importance in Wound Healing Reference
Providing a moist wound
environment
Prevents dehydration and cell death
Promotes epidermal migration and angiogenesis
Maintains moisture at the wound bed
[189]
Removal of excess exudate
Exudate is essential for the wound healing process, but
excess exudate can cause healthy tissue maceration,
resulting in a chronic wound.
[190]
Allows gaseous exchange Oxygenation controls exudate levels and stimulatesepithelialization and fibroblasts. [191]
Prevents infections
Microbial infections delay the wound healing process by
prolonging the inflammatory phase and by inhibiting




Removal of adherent dressing can be painful and can
cause further damage to granulation tissue. [193]
Cost-effective An ideal dressing should assure the wound healingprocess at a reasonable cost. [194]
In addition, it is preferable that wound dressings contribute to skin regeneration. In this regard,
a variety of wound-dressing materials have been developed either based on synthetic or natural
polymers. As seen in Table 4, there are many major types of wound-dressing materials: fibers, gels,
membranes, films, sponges, and hydrocolloids. Although the terms “film” and “membranes” could be
use to describe the same type of wound dressing, referring to a device developed to isolate a surface
from its environment, we have chosen to use and describe the terms separately, mainly due to the fact
that the terms vary among authors [195–199]. Moreover, both terms are used accordingly by experts
from different fields; for example, the term “membrane” is employed mainly in the biological and
health sciences, while professionals from engineering science use the term “film”. The distinction
between the two terms can be made based on the moisture content, as membranes are hydrate films
while films are considered dried membranes [200].
Table 4. Advantages and disadvantages of major wound dressings.
Wound




• sustain a moist environment
• absorb wound exudates




• unsuitable for third-degree




• high absorption properties
• provide a moist environment
at the wound site
• water retention
• oxygen permeability




• need for a
secondary dressing
[127,135,203]
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• high absorption properties
• can be cytotoxic
• have an unpleasant odor
• low mechanical stability




• impermeable to bacteria
• allows the healing process to
be monitored
• painless removal
• hard to handle
• non-absorbent









• assure gas exchange, cell
proliferation, and
nutrient supply
• the materials and solvents
used in the production




• high porosity and
absorption capacity
• mimic the skin’s
extracellular matrix
• unsuitable for third-degree,
eschar, and dry wounds




The most suitable antimicrobial polymer should be easy and inexpensive to synthesize, stable for
long-term usage, biodegradable and non-toxic, and most importantly, have a biocidal effect to a broad
spectrum of pathogens [207]. Chitosan, as a natural cationic polysaccharide, seems to possess all of the
above-mentioned properties [128]. Moreover, the difference between chitosan-based products and
traditional dressings like gauze or cotton wool is that chitosan participates actively in wound healing
processes [188].
Chitosan derivatives have become important tools in many different areas such as water
purification [208–211], food and paper industries [212–215], and most importantly, medicine and
pharmacy [127,135,216,217]. Allan et al. were amongst the first to propose the antimicrobial activity
of chitosan [218], and since then, the idea of developing chitosan derivatives has become more and
more pronounced amongst scientists. In Table 5, the effects of different types of chitosan on some
pathogenic microorganisms are presented. Although we cannot compare the results obtained in
different experimental studies, within the same set of experiments, we can evaluate the effect of
chitosan on different species of microorganisms. Because human health can be severely impaired by
pathogenic microorganisms, the search for more efficient antimicrobial agents is even more imperative.
Table 5. Antimicrobial effect of chitosan derivatives demonstrated using the agar diffusion method.
Chitosan-Based Wound Dressing Degree ofDeacetylation % Pathogenic Microorganism
Inhibition Zone
Diameter Reference
Chitosan/chitin/glucan nonwoven mats n.a.
E. coli (−) 12 mm
[219]
K. pneumoniae (−) 8 mm
S. aureus (+) 13 mm
Bacillus. subtilis (+) 11 mm
Alginate/chitosan-based bilayer





inhibitory effect [220]P. aeruginosa (−)
S. aureus (+)
Alginate–chitosan hydrogel loaded with
tetracycline hydrochloride n.a.
E. coli (−) 10.5 mm
[221]
S. aureus (+) 10 mm
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E. coli (−) pronounced
inhibitory effect [222]S. aureus (+)
Chitosan films with Hypericum perforatum
oil (1% w/v chitosan film incorporated
with 1.5% v/v H. perforatum oil)
85%
E. coli (−)
(20 mm inhibition zone for




(12.4 mm inhibition zone for








E. coli (−) ATCC 35218
S. aureus (+) ATCC 25923
S. aureus ssp. aureus (+)
ATCC29213






E. coli (−) 7.04 mm
[181]
S. aureus (+) 10.56 mm
Chitosan–glycerol membrane loaded
with silver sulfadiazine
E. coli (−) 5.32 mm
S. aureus (+) 3.52 mm
Chitosan–Ag nanoparticle bilayer sponge
93.70%
S. aureus (+) 3 mm
[224]E. coli (−) 2 mm




E. coli (−) 10.35 ± 0.12 mm
[225]




(1.8% v/v Thymol) 6.4 ± 0.9 mm
[226]
S. aureus (+)
(1.8% v/v Thymol) 10.5 ± 1.8 mm
Bacterial cellulose–chitosan membranes 90%
E. coli (−) no inhibition zone
[227]
S. aureus (+) no inhibition zone
n.a.—data not available.
6.1. Chitosan Fibers
There are several common ways to produce chitosan fibers, the first published data being reported
in 1926 [90]. Fibers can be produced by a dry and wet spinning method using different solvents. A more
recent technique used by modern-day scientists is electrospinning (ESP). The main advantage of this
method is that it allows the fabrication of polymer nano- and microfibers, depending on the processing
conditions [228]. Porous fiber membranes have a large potential in wound-healing applications due to
their high porosity and the ability to mimic the skin’s extracellular matrix.
Zhou et al. synthesized N,N,N-trimethyl chitosan (TMC) fibers with different degrees of
quaternization (DQ 19%, 25%, and 32%). TMC fibers showed higher antibacterial activity against
Gram-negative E. coli (>63%) and Gram-positive S. aureus (>99%) than chitosan fibers (24%). In addition,
TMC fibers showed no cytotoxicity toward mouse fibroblasts and the TMC DQ of 25% significantly
increased wound reepithelization compared to the control (chitosan fibers). The results indicated that
a high DQ increased antibacterial activity due to the quaternary ammonium groups with permanent
positive charges. The cationic charge is the key to the binding process of the polymer to the negatively
charged bacterial cell membrane [229].
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6.2. Chitosan Hydrogels
Hydrogels are 3D polymer networks that can absorb large amounts of water and are moist,
flexible, and soft materials with a wide range of applications in biomedical fields. The high content of
water and the mechanical properties of hydrogels make them compatible with most living tissues, and
they improve the healing process [127]. The hydrophilic gel keeps the wound bed moist, providing a
non-adherent environment, and their swelling capacity helps with wound exudate absorption [230].
Another advantage of hydrogels is that they can follow the geometry of the wound, assuring a good
superficial contact, which can be very helpful even in third-degree burns [165].
In addition to their main purpose (drug and/or growth factor delivery while speeding up
the healing process), hydrogels must also prevent the microbial infections that can develop in
this moist environment. Antimicrobials can be either covalently bound to the hydrogel network,
noncovalently encapsulated in hydrogels, or the hydrogel can possess inherent antimicrobial properties.
Amongst other antimicrobial polymer-based gels, chitosan-based hydrogels are of great interest for the
scientists [231].
6.3. Chitosan Membranes
Amongst the variety of wound dressings available, the porous membrane dressings are considered
to be the ones that meet most of the requirements of an ideal wound dressing [51]. However, the moist
environment provided by membranes also facilitates pathogen proliferation, thus it is highly necessary
to impregnate the membranes with an antimicrobial agent.
The simplest method of developing chitosan membranes is a solution casting–evaporation
technique, by which chitosan is first solubilized in acetic acid solution [232]. The main drawback of this
method is that acetic acid, along with chemical cross-linkers, such as carbodiimide or glutaraldehyde,
among others, possess cytotoxic effect on mammalian cells; therefore, this is a major limitation to
wound healing. To overcome these disadvantages, Ma et al. developed chitosan–glycerol membranes
loaded with tetracycline hydrochloride (TH) and silver sulfadiazine (AgSD) through a simple solution
casting–evaporation method and evaluated the bacterial growth inhibition against E. coli and S. aureus by
measuring the inhibition zone diameter. The difference was that they used chitosan floccule suspension
instead of an acetic acid solution. Thus, chitosan–glycerol membranes loaded with antibacterial agents
not only inhibited bacterial growth in a significant manner, but glycerol also enhanced the membranes’
mechanical properties, promoting wound healing [233].
6.4. Chitosan Films
Güneş et al. developed a chitosan-based film incorporating Hypericum perforatum oil that proved
to have an antimicrobial effect on E. coli and S. aureus. The results showed that the antimicrobial
effect increases with the concentration of essential oil incorporated into the chitosan matrix. Thus,
the diameter of the zone of inhibition of simple chitosan films against E. coli was 2 cm compared to
2.9 cm in the case of chitosan films incorporated with 1.5% H. perforatum oil. S. aureus proved to be
more resistant than E. coli, with a diameter of the inhibition zone of chitosan films with an essential oil
concentration of 1.5% equal to 1.97 cm [223].
There are numerous chitosan-based products on the market, and one example is the HemCon®
dressing, which is a chitosan acetate bandage that was designed as a hemostatic dressing with
antimicrobial properties. Burkatovskaya et al. investigated its effect on infected and non-infected
excisional wounds in mice. The wounds infected with Gram-negative species (P. aeruginosa and
Proteus mirabilis) and left untreated led to serious infections that caused the death of mice, but the
chitosan acetate bandage applied on the infected area rapidly killed bacteria [126].
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6.5. Chitosan Sponges
Sponges are foam-like, solid structures that can absorb large amounts of liquid due to their high
porosity. Besides possessing antimicrobial properties, chitosan sponges are widely used as wound
dressings, being able to absorb wound exudates and also enhancing tissue regeneration [165].
Anisha et al. developed an antimicrobial chitosan–hyaluronic acid/nanosilver composite
sponge for the treatment of infected diabetic wounds. The sponges showed an antibacterial
effect against the major bacterial strains known to infect a wound (E. coli, S. aureus, P. aeruginosa,
K. pneumoniae, and even MRSA—Methicillin-resistant Staphylococcus aureus). However, cytotoxicity
tests showed that higher concentrations of nanosilver in the sponges decreased cell viability [234].
Another study published by Shao et al. showed that silver-sulfadiazine-loaded chitosan composite
sponges had high porosity and excellent swelling behaviors and possessed a broad spectrum of
antibacterial activity (E. coli, C. albicans, S. aureus, and B. subtilis). The cell viability results performed
by 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) viability assay and
fluorescence staining method on HEK293 cell lines indicated that the sponges had no significant
cytotoxicity; therefore, CS/AgSD composite sponges have potential applications as antimicrobial
wound-dressing materials [235]. Pei et al. fabricated AgNP-loaded silk fibroin (SF)/carboxymethyl
chitosan (CMC) composite sponges that showed effective antibacterial activity against S. aureus and
P. aeruginosa. The addition of CMC increased the water vapor transmission rate and improved the
water absorption capacity and retention ability of the sponge, all of these being important properties of
a wound dressing [236]. Mi and team developed a sponge-like asymmetric chitosan membrane
by an immersion–precipitation phase-inversion method. The sponge-like membranes showed
many advantages a wound dressing requires, such as excellent oxygen permeability, and controlled
evaporative water loss, promoted fluid drainage ability, and inhibited exogenous microorganism
invasion due to the inherent antimicrobial properties of chitosan. Moreover, histological tests on rat
wounds showed an increased epithelialization rate and well-organized deposition of collagen in the
dermis [237].
6.6. Chitosan Hydrocolloids
The composition of a hydrocolloid consists of an external layer of polyurethane and one
internal layer composed of hydrophilic colloidal particles (carboxymethylcellulose, gelatin, pectin).
A hydrocolloid dressing will absorb wound exudate due to its internal layer of gelatin, pectin, and
carboxymethylcellulose. The external polyurethane layer will seal the wound, not only enabling gas
exchange and preventing external contamination of the wound, but also maintaining an acidic pH at
the wound bed, facilitating autolytic debridement [90,204]. In addition, they promote angiogenesis,
increase the number of fibroblasts and the number of collagen fibers, and enhance the production of
granulation tissue, all of each are very important steps in the healing process [204].
Hiranpattanakul et al. developed a chitin/chitosan hydrocolloid (CCH) wound dressing, and
properties like their water absorption, enzymatic degradation, and antibacterial activity against
Gram-positive and Gram-negative bacteria were evaluated, as well as their biocompatibility with the
L929 cell line. The CCH showed antibacterial activity against E. coli and S. aureus and showed no
cytotoxicity against the L929 fibroblasts [231]. Yanagibayashi et al. developed another functionalized
wound dressing to stimulate wound healing in diabetic mice. The hydrocolloid composed of alginate,
chitin/chitosan, and fucoidan (ACF-HS) had important properties like adherence, ease of application
and removal, providing a moist environment, and absorbing exudate. Moreover, the histological
examinations of the wounds showed advanced tissue and capillary formations, starting on the 4th day
of treatment [238].
The multitude of wound dressings already existing on the market, from sponges to granules, gels,
and sprays, only prove that chitosan is a promising polymer for wound-healing applications, being
versatile and suitable for many types of wounds (Table 6). Although the majority of chitosan-based
wound dressings, presented below, are hemostatic dressings developed to stop moderate to severe
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bleeding, they also have specific features that direct them to certain types of wounds. For example,
Chitoderm® plus is a wound dressing based on a strong non-adhesive superabsorber, with chitosan
coating, that has bacteriostatic action and actively accelerates healing processes. The manufacturer
recommends it for numerous types of wounds, from acute to chronic, exudating, contaminated wounds,
venous leg ulcers, diabetic, and first- and second-degree burns [239]. Another product, Celox™, is
a hemostatic chitosan-based wound dressing that clots hypothermic blood and blood treated with
blood-thinning drugs, can be easily removed from the wound site, and the residual material is naturally
absorbed by the body [240]. The manufacturers of Opticell gelling fibers had an interesting approach
in developing this chitosan-based dressing. Not only can the dressing be worn up to seven days, but
the chitosan-based Cytoform technology allows the absorbent fibers within the dressing to transform
into a gel. Indicated for the control of minor bleeding, the gelling action helps manage drainage and
the removal of dead, damaged tissue, trapping it until the later removal of the dressing [241]. A similar
approach is seen for the LQD spray dressing, which contains chitosan as active ingredient, that has
been modified to have the highest degree of deacetylation of any chitosan product and a much higher
positive charge. The LQD spray is applied as a spray and within two minutes of application, it forms a
chitosan membrane over the wound. This dressing, which is indicated for the external treatment of
chronic and acute wounds and superficial and partial thickness burns, providing physical protection
and suppressing the secretion of proinflamatory cytokines, contributing to pain relief, has a hemostatic
and antibacterial effect [242].
The current regulatory status of chitosan given by the US FDA (United States Food and
Drug Administration) is defined as GRAS (generally recognized as safe) for wound-dressing
applications [243–245] and also tissue engineering [246,247]. Moreover, chitosan has been approved
as a dietary supplement in Japan, Italy, and Finland [248]. Therefore, there is a growing number of
chitosan wound dressings that meet the requirements of various types of wounds, and due to the
advantages provided by this polymer, the use of chitosan as a wound-dressing material will only be
increasing in the future.
Table 6. Chitosan-based wound dressings on the market.
Product Dressing Type Material Producer
Axiostat® Sponge 100% chitosan Axiobio
Chitoderm® plus Superabsorber
Strong superabsorber coated with
chitosan Trusetal
ChitoSAM™ 100 Non-woven chitosan dressing spundirectly from chitosan 100% chitosan Sam Medical
Celox™ Gauze (Celox Rapid, Celox Gauze)Granules (Celox A, Celox Granules)
Chito-R™ activated chitosan
granules MedTrade
ChitoClear® Gel or liquid spray
ChitoClear® positively charged









Hemostatic dressing active on
both sides
Chitosan-based dressings Tricol Biomedical
ChitoGauze® PRO Chitosan-coated gauze
ChitoDot® Double-sided hemostatic dressing
HemCon® Bandage PRO Hemostatic bandage
HemCon Patch® PRO Non-invasive hemostatic patch
HemCon® Strip PRO Hemostatic bandage
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Table 6. Cont.
Product Dressing Type Material Producer
KytoCel Gelling fiber Chitosan fibers Aspen Medical







nasal dressing Chitosan lactate Stryker
XSTAT Hemostatic device containingsuperabsorbent sponges of chitosan
Wood pulp sponges coated with
chitosan RevMedX
Alchite (University of





positive charge and the highest




ChitoHeal Gel N-acetyl-d-Glucosamine (chitosan) ChitoTech
ChitoClot Bandage non-woven dressing 100% chitosan-based, non-wovenwith adhesive back sheet BenQ Materials




Distilled water, chitosan, xylitol,




Distilled water, all-natural sea salt,
chitosan, xylitol, methylcellulose,
aloe vera, grapefruit seed extract,
citric acid
7. Conclusions
There is no doubt that chitosan possesses important features that can be very helpful in solving
modern-day challenges regarding various areas of interest such as biomedicine, pharmaceutical,
cosmetic, and food industries, wastewater treatment, and agricultural pest management.
Chitosan may be one of the most important biopolymers that can be used to produce wound
dressings that not only accelerate the wound healing process but also prevent infection of the wound,
a necessary step in the wound healing process.
The mechanism of action against microbial cells is not entirely defined, but numerous studies
have presented similar results; therefore, researchers have formulated some hypotheses by which
chitosan can inhibit microbial growth:
(1) electrostatic interactions occur between cationic chitosan and anionic molecules at the microbial
cell surface, which may lead to cell wall disruption and intracellular components leakage;
(2) LMW chitosan can penetrate the cell membrane and interact with DNA, thereby interfering
with protein synthesis processes;
(3) Another mechanism of action for chitosan would be the chelation of nutrients and essential
metals that are fundamental to cell stability.
Used as a wound dressing, chitosan stimulates the natural healing process and has no toxicity to
the mammalian cell. Being biocompatible, chitosan has a known metabolic pathway. Once it enters the
human body, it can be hydrolyzed by enzymes, such as lysozyme, present in mucus, tears, and saliva,
to an important sugar, glucosamine, that it is already present in the human body.
The existence of numerous chitosan-based wound dressings on the market shows the importance
of this biopolymer in accelerating the wound healing process, and we may consider chitosan as a
cost-effective solution not only for the treatment of acute wounds but also in the case of severe chronic
wounds, such as diabetic ulcers.
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